EVAX - Evaxion Biotech A/S

QQQ $ 473.06 $ -2.91 (-0.61 %)

DIA $ 416.90 $ -1.09 (-0.26 %)

SPY $ 562.37 $ -2.76 (-0.49 %)

TLT $ 100.96 $ -0.43 (-0.43 %)

GLD $ 237.46 $ -0.52 (-0.22 %)

Previous Close

$ 3.25

Open

$ 3.24

Bid

$ 3.16 x 100

Ask

-- x --

Day's Range

$ 3.03 - $ 3.24

52 Week Range

$ 2.26 - $ 13.61

Volume

499,773

Average Volume

Market Cap

123.17M

Beta (5Y Monthly)

$ 1.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evaxion Biotech Announces One-year Data Fr...
09/16/2024 11:03:45

11 out of 16 patients had objective clinical responses, equaling a 69% Overall Response Rate15 out of the 16 patients had a red...

Evaxion Announces Data From Interim Analys...
09/09/2024 12:05:14

Evaxion Biotech Unveils Pre-Clinical Resul...
09/09/2024 11:03:43

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunolog...

HC Wainwright & Co. Reiterates Buy on Evax...
08/16/2024 09:42:38

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Evaxion Biotech's Cash Position Of $8M As ...
08/14/2024 11:05:04

Evaxion Biotech Q2 2024 GAAP EPS $(0.12) B...
08/14/2024 11:04:08

Evaxion To Present 1-Year Clinical Efficac...
08/08/2024 12:05:57

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunolog...

HC Wainwright & Co. Reiterates Buy on Evax...
08/01/2024 12:20:05

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Evaxion CEO Christian Kanstrup Reinforces ...
07/03/2024 12:13:30

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

Evaxion, On Patent Application for AI-Base...
06/26/2024 11:31:59

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
06/19/2024 20:30:52

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

Evaxion Announces Publication Of Data From...
06/17/2024 12:46:33

HC Wainwright & Co. Reiterates Buy on Evax...
06/04/2024 11:17:30

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Evaxion Presents Validating Immune Data Fr...
06/03/2024 12:47:34

Evaxion's AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melan...

Evaxion Biotech Q1 EPS $0.03 Beats $(0.56)...
05/28/2024 12:30:00

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.5...

Evaxion Received A Letter From The Nasdaq ...
05/10/2024 21:03:50

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

Evaxion Biotech Files For For Offer And Sa...
05/06/2024 21:12:04

Evaxion Announces First Patient Completed ...
04/17/2024 12:09:57